A Prospective, Noninterventional, Observational Study of Late-Onset Pompe Disease

Clinical trial NCT02221362 · TERMINATED

Trial details

NCT number: NCT02221362
Sponsor: BioMarin Pharmaceutical
Status: TERMINATED
Study type: OBSERVATIONAL

Late-onset Pompe Patients Untreated or Treated With rhGAA

Start date: 2014-12-01
Primary completion: 2016-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.